|
Post by mango on Jun 3, 2017 14:36:52 GMT -5
The Food and Drug Law Institute: Introduction to U.S. Drug Law and RegulationJune 14-15, 2017 Boston, MA Agenda—June 15, 2017 • 11:30 AM–12:45 PM
Regulation of Drug Manufacturing David S. Weinstock, Senior Counsel, MannKind Corporation • 2:00–3:30 PM
Regulation of Drug Marketing David S. Weinstock, Senior Counsel, MannKind Corporation www.fdli.org/2017/06/introduction-u-s-drug-law-regulation/
|
|
|
Post by scander on Jun 3, 2017 23:49:10 GMT -5
I would say waste of $$$ unless someone else is sponsoring the cost
|
|
|
Post by promann on Jun 4, 2017 7:18:19 GMT -5
I appreciate mango! Any new news relating to MNKD and posted here is great! As far as a senior Counsel for Mannkind speaking of FDA Laws and Regulations that speaks highly of this senior Counsel for MNKD he must have high Knowledge in this area and that is good to see since we are trying to get a better label approved. 2nd I really don't think a main speaker at this assembly is paying to be there if anything they are paying him to go speak.
|
|
|
Post by bioexec25 on Jun 4, 2017 8:30:53 GMT -5
Pretty good timing for Mannkind senior counsel to go to a conference where advertising rules and pricing issues are being discussed. Read through the whole agenda and yes good idea to go and speak. God knows Weinstock has a lot he could contribute and gain. Since coming to Mannkind couple years back he was Sr Counsel at Bayer. Experience with Allergan and legal work for Novo.
|
|